Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems
- 26 April 2010
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 107 (19), 8531-8536
- https://doi.org/10.1073/pnas.1001721107
Abstract
RNA molecules perform diverse regulatory functions in natural biological systems, and numerous synthetic RNA-based control devices that integrate sensing and gene-regulatory functions have been demonstrated, predominantly in bacteria and yeast. Despite potential advantages of RNA-based genetic control strategies in clinical applications, there has been limited success in extending engineered RNA devices to mammalian gene-expression control and no example of their application to functional response regulation in mammalian systems. Here we describe a synthetic RNA-based regulatory system and its application in advancing cellular therapies by linking rationally designed, drug-responsive, ribozyme-based regulatory devices to growth cytokine targets to control mouse and primary human T-cell proliferation. We further demonstrate the ability of our synthetic controllers to effectively modulate T-cell growth rate in response to drug input in vivo. Our RNA-based regulatory system exhibits unique properties critical for translation to therapeutic applications, including adaptability to diverse ligand inputs and regulatory targets, tunable regulatory stringency, and rapid response to input availability. By providing tight gene-expression control with customizable ligand inputs, RNA-based regulatory systems can greatly improve cellular therapies and advance broad applications in health and medicine.Keywords
This publication has 30 references indexed in Scilit:
- Design Principles for Riboswitch FunctionPLoS Computational Biology, 2009
- Frameworks for Programming Biological Function through RNA Parts and DevicesCell Chemical Biology, 2009
- Higher-Order Cellular Information Processing with Synthetic RNA DevicesScience, 2008
- Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primatesJCI Insight, 2008
- A modular and extensible RNA-based gene-regulatory platform for engineering cellular functionProceedings of the National Academy of Sciences of the United States of America, 2007
- Principles of adoptive T cell cancer therapyJCI Insight, 2007
- Phase I Study of Adoptive T-Cell Therapy Using Antigen-Specific CD8+ T Cells for the Treatment of Patients With Metastatic MelanomaJournal of Clinical Oncology, 2006
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Adoptive immunotherapy for cancer: building on successNature Reviews Immunology, 2006
- Pharmacologically regulated in vivo selection in a large animalBlood, 2002